Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed Mar 30, 2021 · 10-K · 89 days after period end · 0001564590-21-016682
| Metric | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|
| Net Income | -$53.72M | -$98.01M | -$484.00K |
| EPS Diluted | -$1.58 | -$3.97 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 30, 2021 · 89 d after period end
